Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

45,809 stories, page 664 of 764

Advanced search

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Drug Discovery Technologies Market 2026-2030 | In

GlobeNewswireOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

London Biotech Biz To Buy Cancer-Focused US Co. For £17M

Law360Original source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

6 Biotech Stocks That Delivered Stunning Gains: INBX +700%, PVLA +500%, MBX +300%, ABSI +200% & More

RTTNewsOriginal source

🌍Jun 24discoverynews.google.comTier 2 · Trade media

Novartis targets undruggable cancers with $1.9bn Antares Therapeutics deal

Pharmaceutical TechnologyOriginal source

🌍Jun 24discoverynews.google.comTier 2 · Trade media

Endpoints 100 survey: Biotech CEOs predict MFN maneuvering and offer a few ideas for the FDA

Endpoints NewsOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

The Brown Capital Management Small Company Fund Bets on Krystal Biotech (KRYS) for Its Resilient Revenue Stream

Yahoo Finance UKOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Helus Pharma stock jumps on Phase 3 trial enrollment progress By Investing.com

Investing.com South AfricaOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Lundbeck's new R&D boss welcomes promotion

medwatch.comOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

HHS Secretary Kennedy says US should lead in medical research, innovation

Baltimore SunOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Jules Monneret: Had the Opportunity to Explore Pharmaceutical RandD at Servier France

OncodailyOriginal source

🌍Jun 24discoverynews.google.comTier 2 · Trade media

Abbott pens blood-based Alzheimer's testing pact with ALZpath

Fierce BiotechOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Roundtable: Patient Services Leaders on the Pressures Shaping Hubs in 2026

Pharmaceutical CommerceOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Osanni Bio raises $190 million Series B to advance therapeutics platform

The PharmaletterOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Medicines storage needs to change with the climate

The Pharmaceutical JournalOriginal source

🌍Jun 24discoverynews.google.comTier 2 · Trade media

Finetech Debuts Fully Automatic Liquid Capsule Filling Machine at CPhI China 2026 in Shanghai

BioSpaceOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Fake Cancer Medicines Have Reached US Clinics And Most Providers Don’t Know It

Health AffairsOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress - Wed, 06/24/2026 - 06:00

Helus PharmaOriginal source

🇿🇦Jun 24Researchsu.ac.zaTier 3 · Secondary coverage

Reshard's path from Stellenbosch to Yale

Stellenbosch UniversityOriginal source

🇺🇰Jun 24Regulatorygov.ukTier 1 · Regulatory source

Martha's Rule extended to all maternity services

Landmark patient safety initiative, Martha's Rule, rolled out to all maternity settings after review...

UK Department of Health and Social CareOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Viking Therapeutics begins phase 1 trial of weight loss drug

Investing.comOriginal source

🇨🇦Jun 24Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

UHI-4 High Flow Insufflation System - Insufflator

Olympus identified an increase in UHI-4 front-panel 'blackout' complaints, where the front-panel dis...

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Jun 24Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Infinion™ CX Contact Lead Kit

Boston Scientific is initiating a voluntary removal of unused Infinion™ CX Leads as part of the plan...

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Jun 24Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Argon Medical Devices L-Cath™ PICC and Midline Catheters

Reports of leaking and/or cracking at the hub of the affected products. A cracked catheter hub on a...

Health Canada Recalls and Safety AlertsOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Biotech Visionary Is Skeptical About AI’s Impact on Medical Innovation

Bloomberg.comOriginal source

🌍Jun 24discoverynews.google.comTier 2 · Trade media

Insulet hires Convatec, Eli Lilly alum as new R&D chief

Fierce BiotechOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching

24/7 Wall St.Original source

🇺🇰Jun 24Regulatorygov.ukTier 1 · Regulatory source

Clostridioides difficile infection: how to deal with the problem

Interim update to the guidance on the most effective methods of prevention and control of Clostridio...

UK Department of Health and Social CareOriginal source

🌍Jun 24discoverynews.google.comTier 2 · Trade media

Eli Lilly reunites with Abbisko in $1.9B, multitarget R&D pact

Fierce BiotechOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Unlocking the Sustainability Data Inside Biotech Operations

The Medicine MakerOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Cognition Therapeutics Secures FDA Alignment for Phase 3 Zervimesine Trial in DLB Psychosis

Quiver QuantitativeOriginal source

🇿🇦Jun 24Researchsu.ac.zaTier 3 · Secondary coverage

From one war to another: SU hosts conversation on refugees and migrants

Stellenbosch UniversityOriginal source

🌍Jun 24discoverynews.google.comTier 2 · Trade media

BIO 2026: US needs to dodge China’s ‘inescapable dependencies’ to protect biotech

BioSpaceOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress

Investing News NetworkOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Drug compounding was meant for individuals. Empower Pharmacy serves 70K a week.

Houston ChronicleOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Pharmacists warn of UK medicine shortages amid US drug recall

MSNOriginal source

🇺🇰Jun 24Regulatorygov.ukTier 1 · Regulatory source

Ockenden review into maternity services at Nottingham University Hospitals NHS Trust: final report

Findings, conclusions and essential actions from the independent review of maternity services at Not...

UK Department of Health and Social CareOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Viking starts first human test of VK3019 for weight loss

Stock TitanOriginal source

🌍Jun 24discoverynews.google.comTier 2 · Trade media

Ophthalmology venture grabs investors’ attention, raises $330 million

statnews.comOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

VERAXA adds 60% more lab space in Heidelberg for cancer drug work

Stock TitanOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

FDA gives CalciMedica no comments on Auxora safety review

Stock TitanOriginal source

🌍Jun 24discoverynews.google.comTier 2 · Trade media

Ollin hauls in $330M to enlist Vabysmo challenger in phase 3 eye disease gauntlet

Fierce BiotechOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026

Business WireOriginal source

🌍Jun 24discoverynews.google.comTier 2 · Trade media

ŌURA and Lilly join forces to harmonise drug-wearable obesity care

Pharmaceutical TechnologyOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Sun Pharmaceutical Industries rises Wednesday, outperforms competitors

MarketWatchOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

How UPS is Adressing pharmaceutical Procurement Challenges

Procurement MagazineOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Helus Pharma says Phase 3 depression trial is 86% enrolled

Stock TitanOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress

GlobeNewswireOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

FDA cracks down on counterfeit cosmetics, illegal drug sales

The Indian ExpressOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

The new drug compound that could treat measles outbreaks – and other viruses

Drug Discovery NewsOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

CORXEL’s oral obesity drug clears Phase II test

The PharmaletterOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Sangamo files for bankruptcy as Lilly and Astellas target assets

The PharmaletterOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Former Vertex, GSK exec launches science-first pet nutrition company

The Business JournalsOriginal source

🌍Jun 24discoverynews.google.comTier 2 · Trade media

Early Biomarkers as Predictors of Nephrology Trial Trajectory

Pharmaceutical TechnologyOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

FDA Advisory No.2026-0670 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “JIE TOU QI SHI”

fda.gov.phOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

FDA Advisory No.2026-0669 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “Beauluck Tablet”

fda.gov.phOriginal source

🇿🇦Jun 24Researchsu.ac.zaTier 3 · Secondary coverage

South Africa needs the mother of all in(ter)ventions

Stellenbosch UniversityOriginal source

🌍Jun 24discoverynews.google.comTier 2 · Trade media

The Things to Think About Before Taking Your Biotech Company Public

MedCity NewsOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

USFDA Rejects Achieve's Smoking-Cessation Drug Cytisinicline Over Manufacturing Issues

Medical DialoguesOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Revolution Medicines Begins Treating Patients in RASolute 305, a Phase 3 Clinical Trial Evaluating Zoldonrasib in Combination with Chemotherapy as a First Line Treatment for Patients with RAS G12D Metastatic Pancreatic Cancer

SahmOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Europe Approves Sanofi's Multiple Sclerosis Drug Despite FDA Rejection

SahmOriginal source